| Entry |
|
|---|
| Name |
Pralidoxime mesylate (USAN) |
|---|
| Formula |
C7H9N2O. CH3SO3
|
|---|
| Exact mass |
232.0518
|
|---|
| Mol weight |
232.2569
|
|---|
| Structure |
|
|---|
| Remark |
| Product (DG01153): | D00469<US> D01572<JP> |
|
|---|
| Efficacy |
Antidote (organicphosphorus compound), Acetylcholinesterase (AChE) reactivator |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB04 Pralidoxime
D05590 Pralidoxime mesylate (USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D05590 Pralidoxime mesylate (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 15
1 C8y C 23.2283 -18.4177
2 N5y N 22.0116 -17.7100 #+
3 C8x C 23.2283 -19.8160
4 C2b C 24.4452 -17.7100
5 C8x C 20.8006 -18.4177
6 C1a C 22.0116 -16.3235
7 C8x C 22.0116 -20.5237
8 N2b N 25.6444 -18.4177
9 C8x C 20.8006 -19.8160
10 O1b O 26.8669 -17.7100
11 O1d O 31.6296 -17.2429
12 S4a S 31.6296 -18.6389
13 C1a C 30.2338 -18.6389
14 O1d O 33.0256 -18.6389 #-
15 O1d O 31.6296 -20.0348
BOND 14
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 4 8 2
8 5 9 2
9 8 10 1
10 7 9 1
11 11 12 2
12 12 13 1
13 12 14 1
14 12 15 2
|
|---|
